se of Cashew Nut Flour on children with Human Immunodeficiency Virus

Not Applicable

• Conditions: Human immunodeficiency virus; C01.925.782.815

• Registration Number: RBR-6sf6njs
• Lead Sponsor: Ana Cristina Pereira de Jesus Costa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-01-30
• Study Start: 2023-02-23
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Term birth. Receiving Anti-Retroviral Therapy for HIV for at least ninety days. Preserved kidney and liver function

Exclusion Criteria

User of psychotropic or antimicrobial or antineoplastic drug. Have started intervention to recover nutritional status. Have an allergy to cashew nut products

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expected to find a mean difference in blood hemoglobin verified through analytical statistics of at least 7g/dL after the intervention.<br>

Secondary Outcome Measures

Name	Time	Method
Expected to find a body mass index between the 5th and 85th percentile verified through analytical statistics for each age and gender.